ASPCF - Acerus Pharmaceuticals Corporation (ASPCF) CEO Edward Gudaitis on Q2 2019 Results - Earnings Call Transcript
Acerus Pharmaceuticals Corporation (ASPCF)
Q2 2019 Earnings Conference Call
August 7, 2019 8:30 A.M. ET
Company Participants
Robert Motz - Chief Financial Officer
Edward Gudaitis - President and Chief Executive Officer
Conference Call Participants
André Uddin - Mackie Research Capital
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Second Quarter 2019 Conference Call for Acerus Pharmaceuticals Corporation. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow this discussion [Operator Instructions] As a reminder, this conference is being recorded. It will be available for replay through